Healthcare provider profile · identity verified

Mark Stanley Mellstrom, M.D.

Family Practice · RED WING, MN · NPI 1346302106

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1005	64
Levothyroxine Sodium	Levothyroxine Sodium	767	53
Sertraline Hcl	Sertraline Hcl	712	39
Lisinopril	Lisinopril	613	41
Gabapentin	Gabapentin	608	47
Potassium Chloride	Potassium Chloride	599	39
Furosemide	Furosemide	562	48
Omeprazole	Omeprazole	559	40
Eliquis	Apixaban	512	32
Duloxetine Hcl	Duloxetine Hcl	430	27
Pantoprazole Sodium	Pantoprazole Sodium	416	44
Amlodipine Besylate	Amlodipine Besylate	409	30
Metoprolol Tartrate	Metoprolol Tartrate	408	32
Torsemide	Torsemide	372	28
Simvastatin	Simvastatin	363	21
Losartan Potassium	Losartan Potassium	298	26
Allopurinol	Allopurinol	293	21
Trazodone Hcl	Trazodone Hcl	254	21
Tamsulosin Hcl	Tamsulosin Hcl	239	24
Metoprolol Succinate	Metoprolol Succinate	225	29
Metformin Hcl	Metformin Hcl	182	suppressed
Warfarin Sodium	Warfarin Sodium	181	13
Prednisone	Prednisone	154	18
Mirtazapine	Mirtazapine	146	14
Hydrochlorothiazide	Hydrochlorothiazide	140	suppressed
Metformin Hcl Er	Metformin Hcl	134	14
Carbidopa-Levodopa	Carbidopa/Levodopa	133	suppressed
Spironolactone	Spironolactone	129	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	117	19
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	112	24
Fluoxetine Hcl	Fluoxetine Hcl	102	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	98	suppressed
Levetiracetam	Levetiracetam	94	suppressed
Carvedilol	Carvedilol	89	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	89	11
Donepezil Hcl	Donepezil Hcl	88	suppressed
Primidone	Primidone	88	suppressed
Famotidine	Famotidine	83	suppressed
Methenamine Hippurate	Methenamine Hippurate	79	suppressed
Pravastatin Sodium	Pravastatin Sodium	75	suppressed
Diclofenac Sodium	Diclofenac Sodium	73	13
Latanoprost	Latanoprost	71	12
Ropinirole Hcl	Ropinirole Hcl	69	suppressed
Atenolol	Atenolol	68	suppressed
Azithromycin	Azithromycin	68	suppressed
Buspirone Hcl	Buspirone Hcl	66	suppressed
Clopidogrel	Clopidogrel Bisulfate	63	11
Meclizine Hcl	Meclizine Hcl	57	suppressed
Ondansetron Hcl	Ondansetron Hcl	55	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	53	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	53	suppressed
Finasteride	Finasteride	52	suppressed
Alendronate Sodium	Alendronate Sodium	51	suppressed
Citalopram Hbr	Citalopram Hydrobromide	50	suppressed
Oxycodone Hcl	Oxycodone Hcl	49	16
Montelukast Sodium	Montelukast Sodium	48	suppressed
Propranolol Hcl Er	Propranolol Hcl	48	suppressed
Topiramate	Topiramate	46	suppressed
Xarelto	Rivaroxaban	44	suppressed
Bupropion Xl	Bupropion Hcl	43	suppressed
Aripiprazole	Aripiprazole	42	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	42	suppressed
Clonidine Hcl	Clonidine Hcl	41	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	41	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	39	suppressed
Glipizide	Glipizide	37	suppressed
Methotrexate	Methotrexate Sodium	37	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	37	suppressed
Nyamyc	Nystatin	35	17
Tramadol Hcl	Tramadol Hcl	35	12
Baclofen	Baclofen	34	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	34	suppressed
Cefdinir	Cefdinir	33	22
Bupropion Hcl	Bupropion Hcl	32	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	31	29
Nystatin	Nystatin	31	22
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	30	suppressed
Cefadroxil	Cefadroxil	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	16
Hydrocortisone	Hydrocortisone	29	suppressed
Novolog Flexpen	Insulin Aspart	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	27	suppressed
Loperamide	Loperamide Hcl	27	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Anastrozole	Anastrozole	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Albuterol Sulfate	Albuterol Sulfate	25	11
Digoxin	Digoxin	25	suppressed
Lamotrigine	Lamotrigine	25	suppressed
Lubiprostone	Lubiprostone	25	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	12
Amiodarone Hcl	Amiodarone Hcl	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	23	suppressed
Acetazolamide	Acetazolamide	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Roflumilast	Roflumilast	22	suppressed
Methimazole	Methimazole	21	suppressed
Fluconazole	Fluconazole	20	suppressed
Folic Acid	Folic Acid	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Insulin Aspart Flexpen	Insulin Aspart	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	18	suppressed
Carbamazepine Er	Carbamazepine	18	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	16	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	16	suppressed
Levofloxacin	Levofloxacin	16	suppressed
Ozempic	Semaglutide	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Cephalexin	Cephalexin	14	11
Humulin N	Insulin Nph Human Isophane	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Risperidone	Risperidone	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Budesonide	Budesonide	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Klayesta	Nystatin	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error